CBOE vs RJF
Valuation
Profitability
Growth
Financial Health
Dividends
AI Verdict
CBOE presents a stable financial profile with a Piotroski F-Score of 4/9 and a very conservative debt-to-equity ratio of 0.31. While the stock is trading near its growth-based intrinsic value of $307.1, it sits significantly above its defensive Graham Number of $107.24, indicating a high valuation premium. Explosive earnings growth of 60.5% is a primary strength, but a high PEG ratio of 3.83 suggests the market has already priced in most of this growth. Bearish insider activity and a very weak technical trend (10/100) suggest limited immediate upside.
RJF presents a conflicting profile: strong growth and attractive valuation metrics are offset by a critically weak Piotroski F-Score of 2/9, indicating deteriorating fundamental health. While the stock trades at a reasonable P/E of 14.75 and a PEG of 1.00, the bearish technical trend and insider selling suggest a lack of immediate conviction. The significant gap between the Graham Number ($122.91) and Intrinsic Value ($312.4) highlights a tension between defensive value and growth expectations. Overall, the company's operational growth is impressive, but the underlying financial health markers require caution.
Compare Another Pair
Related Comparisons
CBOE vs RJF: Head-to-Head Comparison
This page compares Cboe Global Markets, Inc. (CBOE) and Raymond James Financial, Inc. (RJF) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.
Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.